Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

Toon andere (1) versies

PURPOSE: We measured concentrations of human glandular kallikrein 2 (hK2), total prostate specific antigen (tPSA), free PSA (fPSA) and percent fPSA to evaluate their relationship to total prostate gland volume, benign prostatic hyperplasia (BPH) volume, total prostate cancer (PCa) volume (CaVol) an...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Haese, A, Graefen, M, Steuber, T, Becker, C, Noldus, J, Erbersdobler, A, Huland, E, Huland, H, Lilja, H
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2003

Gelijkaardige items

Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
door: Haese, A, et al.
Gepubliceerd in: (2003)

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
door: Steuber, T, et al.
Gepubliceerd in: (2005)

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
door: Haese, A, et al.
Gepubliceerd in: (2000)

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
door: Haese, A, et al.
Gepubliceerd in: (2003)

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
door: Steuber, T, et al.
Gepubliceerd in: (2002)

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
door: Haese, A, et al.
Gepubliceerd in: (2001)

[Isoforms of free prostate-specific antigen]
door: Haese, A, et al.
Gepubliceerd in: (2004)

Isoforms of free prostate-specific antigen
door: Haese, A, et al.
Gepubliceerd in: (2004)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
door: Haese, A, et al.
Gepubliceerd in: (2004)

Prediction of tumor heterogeneity in localized prostate cancer.
door: Huland, H, et al.
Gepubliceerd in: (2002)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
door: Steuber, T, et al.
Gepubliceerd in: (2007)

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
door: Nurmikko, P, et al.
Gepubliceerd in: (2002)

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
door: Haese, A, et al.
Gepubliceerd in: (2005)

Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
door: Piironen, T, et al.
Gepubliceerd in: (2006)

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
door: Cao, Y, et al.
Gepubliceerd in: (2002)

Age and Prostatic Volume: The Prognosis for Benign Prostatic Hyperplasia
door: Dr. Afsheen Khan, et al.
Gepubliceerd in: (2024-05-01)

Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.
door: Ayush Giri, et al.
Gepubliceerd in: (2015-01-01)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
door: Karli Sreenivasulu, et al.
Gepubliceerd in: (2019-01-01)

Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease.
door: Ylikoski, A, et al.
Gepubliceerd in: (2002)

The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
door: Becker, C, et al.
Gepubliceerd in: (2001)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
door: Ida Bagus O.W. Putra, et al.
Gepubliceerd in: (2016-06-01)

Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer
door: R.S. Pompe, et al.
Gepubliceerd in: (2020-07-01)

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
door: Steuber, T, et al.
Gepubliceerd in: (2007)

A study on survivin expression in prostate cancer and benign prostatic hyperplasia; and its association with pre-operative serum prostate specific antigen and gleason score in prostate cancer
door: Hadi, Normila Abdul
Gepubliceerd in: (2016)

Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
door: Becker, C, et al.
Gepubliceerd in: (2000)

Correlation between prostate volume and prostate-specific antigen in patients diagnosed with benign prostatic hyperplasia
door: Udoh EA, et al.
Gepubliceerd in: (2020-12-01)

RELATION OF TOTAL CHOLESTEROL TO PROSTATE VOLUME AND INTRAVESICAL PROSTATIC PROTRUSION IN BENIGN PROSTATIC HYPERPLASIA PATIENTS
door: Made Devi Desyana Arisandi, et al.
Gepubliceerd in: (2021-07-01)

Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia
door: Brian Garvey, et al.
Gepubliceerd in: (2014-05-01)

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
door: Dominique Thomas, et al.
Gepubliceerd in: (2019-10-01)

Study of CD117 Expression and Its Relationship with Benign Prostatic Hyperplasia and Gleason Score in Prostatic Adenocarcinoma
door: Mehdi Rahmanpour, et al.
Gepubliceerd in: (2023-11-01)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
door: Ebenezer Abotsi, et al.
Gepubliceerd in: (2022-12-01)

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
door: Steuber, T, et al.
Gepubliceerd in: (2006)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
door: Muhammed M. Qalawena, MD, et al.
Gepubliceerd in: (2020-06-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
door: N. B. Tabynbaev, et al.
Gepubliceerd in: (2017-05-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
door: Aulia Nur Fadila, et al.
Gepubliceerd in: (2020-07-01)

Renin-angiotensin and kallikrein-kinin systems: a significance in the benign prostatic hyperplasia pathogenesis
door: M. B. Chibichyan, et al.
Gepubliceerd in: (2019-07-01)

Benign Prostate Hyperplasia: Average Volume in Southwestern Nigerians and Correlation with Anthropometrics
door: T A Badmus, et al.
Gepubliceerd in: (2013-01-01)

Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics
door: T A Badmus, et al.
Gepubliceerd in: (2012-01-01)

Circulating biomarkers for prostate cancer.
door: Steuber, T, et al.
Gepubliceerd in: (2007)

A MICROBIAL CONTAMINATION OF PROSTATIC TISSUE IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
door: Y. L. Naboka, et al.
Gepubliceerd in: (2013-03-01)